
Sign up to save your podcasts
Or


In this episode of The Psychedelic Podcast, Paul F. Austin welcomes Dr. Rachelle Sampson, an executive coach, professor of business at the University of Maryland, and board member at the USONA Institute.
Find episode links, summary, and transcript here: https://thethirdwave.co/podcast/episode-266-rachelle-sampson-llb-phd/?ref=278
Dr. Sampson shares insights from the Connected Leadership Project, a groundbreaking study exploring how psychedelic experiences with psilocybin impact decision-making and leadership in business executives.
Dr. Rachelle Sampson is a distinguished researcher and executive coach. She is Associate Professor of Public Policy at the Robert H. Smith School of Business, University of Maryland, and Senior Research Fellow at the ESG Institute, Wharton School, University of Pennsylvania. Dr. Sampson also serves on the Board of Directors for the Usona Institute, a non-profit conducting clinical trials for psilocybin and 5-MEO-DMT.
Dr. Sampson co-leads a pioneering research project on the impact of psychedelics on leadership creativity and decision-making, driven by her curiosity about the role of business organizations in catalyzing systems change.
Highlights:
Episode Links:
Episode Sponsors:
By Third Wave4.7
306306 ratings
In this episode of The Psychedelic Podcast, Paul F. Austin welcomes Dr. Rachelle Sampson, an executive coach, professor of business at the University of Maryland, and board member at the USONA Institute.
Find episode links, summary, and transcript here: https://thethirdwave.co/podcast/episode-266-rachelle-sampson-llb-phd/?ref=278
Dr. Sampson shares insights from the Connected Leadership Project, a groundbreaking study exploring how psychedelic experiences with psilocybin impact decision-making and leadership in business executives.
Dr. Rachelle Sampson is a distinguished researcher and executive coach. She is Associate Professor of Public Policy at the Robert H. Smith School of Business, University of Maryland, and Senior Research Fellow at the ESG Institute, Wharton School, University of Pennsylvania. Dr. Sampson also serves on the Board of Directors for the Usona Institute, a non-profit conducting clinical trials for psilocybin and 5-MEO-DMT.
Dr. Sampson co-leads a pioneering research project on the impact of psychedelics on leadership creativity and decision-making, driven by her curiosity about the role of business organizations in catalyzing systems change.
Highlights:
Episode Links:
Episode Sponsors:

3,982 Listeners

822 Listeners

7,233 Listeners

11,896 Listeners

884 Listeners

1,874 Listeners

2,631 Listeners

1,491 Listeners

1,918 Listeners

561 Listeners

4,722 Listeners

1,046 Listeners

29,399 Listeners

1,104 Listeners

612 Listeners